EVOK - Evoke Pharma Inc. (EVOK) CEO Dave Gonyer on Q4 2020 Results - Earnings Call Transcript

Evoke Pharma, Inc. (EVOK) Q4 2020 Results Conference Call March 11, 2021 04:30 PM ET Company Participants Dave Gonyer - Chief Executive Officer Matt D’Onofrio - Chief Business Officer Chris Quesenberry - Chief Commercial Officer, Eversana Conference Call Participants Yale Jen - Laidlaw and Company Presentation Operator Good afternoon, and welcome to Evoke Pharma’s Fourth Quarter and Full-year 2020 Earnings Conference Call and Audio Webcast. With me today are Dave Gonyer, Evoke’s Chief Executive Officer; and Matt D’Onofrio, Chief Business Officer; as well as Chris Quesenberry from Eversana as Gimoti Chief Commercial Officer. Earlier today, Evoke issued a press release announcing financial results for the fourth quarter and year-end December 31, 2020. We encourage everyone to read today’s press release as well as Evoke’s annual report on Form 10-K, which is filed with the SEC. The company’s 10-K report and press release are also available on Evoke’s website at www.evokepharma.com.

For further details see:

Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2020 Results - Earnings Call Transcript